TOP TIERMARKET NEWSWIRE

News & sentiment

ORGANON & CO (OGN) — News & AI sentiment

ORGANON & CO (OGN) news roundup. 1 story in the past week, 5 over 30 days. Average 30-day sentiment is 59.2/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $200K — net selling of $200K. US House Periodic Transaction Reports (90-day window): 0 purchases (~$0) and 3 sales (~$49K). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

1

avg sentiment 58/100

30d stories

5

avg sentiment 59.2/100

Insider net (90d)

$200K

0 buys · 1 sells

Congress (90d)

-3

0 buys · 3 sells

OGN news in the last 24 hours, 7 days, 30 days and 90 days

How much OGN coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	OGN stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	1	58/100	OGN headlines →
Last 30 days	5	59.2/100	OGN headlines →
Last 90 days	15	56.8/100	OGN headlines →

Latest stories on OGN

Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors

Business Insider58 · neutralproduct/pr

1d ago

Organon to Report Third Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing

StockTitan50 · neutralgeneral

Oct 19

Organon to present interim Phase 3 study results for MIUDELLA

The Fly58 · neutralproduct/pr

Oct 16

Organon Announces Positive Interim Phase 3 Study Results for MIUDELLA®, a Hormone-Free, Intrauterine Device (IUD), Through 6 Years of Use to Be Presented at the 2026 Society of Family Planning Annual Meeting

StockTitan74 · bullishproduct/pr

Oct 16

Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference

StockTitan56 · neutralproduct/pr

Oct 1

Organon announces U.S. FDA accepted for review Sebela’s sNDA for Miudella

The Fly63 · neutralproduct/pr

Sep 14

Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device

StockTitan63 · neutralproduct/pr

Sep 14

Organon: A Merger-Arbitrage Hold With Limited Upside

Seeking Alpha52 · neutralm&a

Sep 12

Endometriosis Market Analysis 2036: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | AbbVie, Kissei Pharma, Theramex, Hope Medicine, TiumBio, Viramal, Organon

Barchart55 · neutralgeneral

Sep 12

Organon Opens Rems Program For Miudella

The Fly55 · neutralgeneral

Aug 11

Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability

StockTitan63 · neutralproduct/pr

Aug 11

Organon Reports Q2 Results Amid Pending Sun Pharma Merger

TipRanks55 · neutralearnings

Jul 31

Organon declares $0.02 dividend

Seeking Alpha50 · neutralgeneral

Jul 31

Organon Announces Quarterly Dividend

StockTitan50 · neutralgeneral

Jul 31

Organon & Co. (OGN) files 8-K

SEC 8-K50 · neutralgeneral

Jul 31

New Analysis of Phase 3 Pooled Data for Organon’s VTAMA® (tapinarof) cream, 1%, Demonstrates Early, Consistent Improvements in Atopic Dermatitis Patients Across Pediatric Age Groups and in Adults¹

StockTitan63 · neutralproduct/pr

Jul 24

Organon & Co. (OGN) files 8-K

SEC 8-K50 · neutralgeneral

Jul 23

Organon & Co. Shareholders Clear Sun Pharma Merger Deal

Yahoo Top63 · neutralm&a

Jul 23

Organon Issues Supplemental Disclosures on Sun Pharma Merger

TipRanks50 · neutralm&a

Jul 17

Organon & Co. (OGN) files 8-K

SEC 8-K50 · neutralgeneral

Jul 17

Organon to Report Second Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing | OGN Stock News

StockTitan50 · neutralgeneral

Jul 16

Organon & Co: Great Odds, Small Prize, Big Penalty

Seeking Alpha53 · neutralgeneral

Jul 14

Organon to Present New Analysis on VTAMA® (tapinarof) cream, 1%, at the 2026 Society for Pediatric Dermatology Annual Meeting | OGN Stock News

StockTitan56 · neutralproduct/pr

Jul 7

Can Organon & Co. (OGN)’s MIUDELLA Launch Become a Major Driver in Women’s Health Markets?

Yahoo Top63 · neutralproduct/pr

Jun 30

Organon and Henlius launch Prolia and Xgeva biosimilars in Canada

Seeking Alpha63 · neutralproduct/pr

Jun 23

Open OGN in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →